102 related articles for article (PubMed ID: 8467490)
1. Prevention of orthotopic human lung cancer growth by intratracheal instillation of a retroviral antisense K-ras construct.
Georges RN; Mukhopadhyay T; Zhang Y; Yen N; Roth JA
Cancer Res; 1993 Apr; 53(8):1743-6. PubMed ID: 8467490
[TBL] [Abstract][Full Text] [Related]
2. Liposome-mediated in vivo gene transfer of antisense K-ras construct inhibits pancreatic tumor dissemination in the murine peritoneal cavity.
Aoki K; Yoshida T; Sugimura T; Terada M
Cancer Res; 1995 Sep; 55(17):3810-6. PubMed ID: 7641198
[TBL] [Abstract][Full Text] [Related]
3. Retroviral vector-mediated transduction of K-ras antisense RNA into human lung cancer cells inhibits expression of the malignant phenotype.
Zhang Y; Mukhopadhyay T; Donehower LA; Georges RN; Roth JA
Hum Gene Ther; 1993 Aug; 4(4):451-60. PubMed ID: 8399492
[TBL] [Abstract][Full Text] [Related]
4. Anti-tumorigenic effect of a K-ras ribozyme against human lung cancer cell line heterotransplants in nude mice.
Zhang YA; Nemunaitis J; Scanlon KJ; Tong AW
Gene Ther; 2000 Dec; 7(23):2041-50. PubMed ID: 11175317
[TBL] [Abstract][Full Text] [Related]
5. Specific inhibition of K-ras expression and tumorigenicity of lung cancer cells by antisense RNA.
Mukhopadhyay T; Tainsky M; Cavender AC; Roth JA
Cancer Res; 1991 Mar; 51(6):1744-8. PubMed ID: 1998965
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of an oncolytic adenovirus-delivered oncogene small interfering RNA.
Zhang YA; Nemunaitis J; Samuel SK; Chen P; Shen Y; Tong AW
Cancer Res; 2006 Oct; 66(19):9736-43. PubMed ID: 17018633
[TBL] [Abstract][Full Text] [Related]
7. Suppression of colorectal cancer growth using an adenovirus vector expressing an antisense K-ras RNA.
Nakano M; Aoki K; Matsumoto N; Ohnami S; Hatanaka K; Hibi T; Terada M; Yoshida T
Mol Ther; 2001 Apr; 3(4):491-9. PubMed ID: 11319909
[TBL] [Abstract][Full Text] [Related]
8. Growth inhibitory effect of anti-K-ras adenovirus on lung cancer cells.
Alemany R; Ruan S; Kataoka M; Koch PE; Mukhopadhyay T; Cristiano RJ; Roth JA; Zhang WW
Cancer Gene Ther; 1996; 3(5):296-301. PubMed ID: 8894248
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic effect of a retroviral wild-type p53 expression vector in an orthotopic lung cancer model.
Fujiwara T; Cai DW; Georges RN; Mukhopadhyay T; Grimm EA; Roth JA
J Natl Cancer Inst; 1994 Oct; 86(19):1458-62. PubMed ID: 8089864
[TBL] [Abstract][Full Text] [Related]
10. Ribozyme against mutant K-ras mRNA suppresses tumor growth of pancreatic cancer.
Kijima H; Yamazaki H; Nakamura M; Scanlon KJ; Osamura RY; Ueyama Y
Int J Oncol; 2004 Mar; 24(3):559-64. PubMed ID: 14767540
[TBL] [Abstract][Full Text] [Related]
11. A MEK inhibitor (U0126) prolongs survival in nude mice bearing human gallbladder cancer cells with K-ras mutation: analysis in a novel orthotopic inoculation model.
Horiuchi H; Kawamata H; Fujimori T; Kuroda Y
Int J Oncol; 2003 Oct; 23(4):957-63. PubMed ID: 12963974
[TBL] [Abstract][Full Text] [Related]
12. Intrapulmonary IFN-beta gene therapy using an adenoviral vector is highly effective in a murine orthotopic model of bronchogenic adenocarcinoma of the lung.
Wilderman MJ; Sun J; Jassar AS; Kapoor V; Khan M; Vachani A; Suzuki E; Kinniry PA; Sterman DH; Kaiser LR; Albelda SM
Cancer Res; 2005 Sep; 65(18):8379-87. PubMed ID: 16166316
[TBL] [Abstract][Full Text] [Related]
13. Orthotopic xenografts of human pancreatic carcinomas acquire genetic aberrations during dissemination in nude mice.
Reyes G; Villanueva A; García C; Sancho FJ; Piulats J; Lluís F; Capellá G
Cancer Res; 1996 Dec; 56(24):5713-9. PubMed ID: 8971180
[TBL] [Abstract][Full Text] [Related]
14. Suppression of Ki-ras p21 levels leading to growth inhibition of pancreatic cancer cell lines with Ki-ras mutation but not those without Ki-ras mutation.
Aoki K; Yoshida T; Matsumoto N; Ide H; Sugimura T; Terada M
Mol Carcinog; 1997 Oct; 20(2):251-8. PubMed ID: 9364215
[TBL] [Abstract][Full Text] [Related]
15. [The effect of antisense H-ras on growth and metastasis of a high metastatic tumor model of human hepatoma in nude mice LCI-D20].
Liao Y; Tang Z; Sun F
Zhonghua Yi Xue Za Zhi; 1996 Sep; 76(9):650-3. PubMed ID: 9275544
[TBL] [Abstract][Full Text] [Related]
16. [Study of growth inhibition of lung cancer cells by siRNA targeting mutant K-ras gene in vitro and in vivo].
Zhang ZP; Jiang GC; Yang F; Zhou ZL; Wang J
Zhonghua Wai Ke Za Zhi; 2007 Sep; 45(18):1267-70. PubMed ID: 18067742
[TBL] [Abstract][Full Text] [Related]
17. Tissue-targeted antisense c-fos retroviral vector inhibits established breast cancer xenografts in nude mice.
Arteaga CL; Holt JT
Cancer Res; 1996 Mar; 56(5):1098-1103. PubMed ID: 8640767
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of human non-small cell lung tumors by a c-Met antisense/U6 expression plasmid strategy.
Stabile LP; Lyker JS; Huang L; Siegfried JM
Gene Ther; 2004 Feb; 11(3):325-35. PubMed ID: 14737093
[TBL] [Abstract][Full Text] [Related]
19. Retroviral gene transfer of dominant negative raf-1 mutants suppresses ha-ras-induced transformation and delays tumor formation.
Heinicke T; Radziwill G; Nawrath M; Rommel C; Pavlovic J; Moelling K
Cancer Gene Ther; 2000 May; 7(5):697-706. PubMed ID: 10830717
[TBL] [Abstract][Full Text] [Related]
20. Postoperative immuno-gene therapy of murine bladder tumor by in vivo administration of retroviruses expressing mouse interferon-gamma.
Shiau AL; Lin CY; Tzai TS; Wu CL
Cancer Gene Ther; 2001 Jan; 8(1):73-81. PubMed ID: 11219496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
